Skip to content
Review Open access

AKI as a systemic syndrome and its impact on other organ systems

Aug 2026 · Critical Care · Vol 30 · 0 citations · 178 references
Medicine

TL;DR

The pathophysiological mechanisms underlying AKI-associated remote organ dysfunction are outlined, focusing on five key organ systems: the lungs, the brain, the heart, the liver and the immune system, and alternative and surrogate outcomes are analyzed.

Abstract

Acute kidney injury (AKI) affects approximately 15% of all hospitalized individuals and nearly half of those admitted to intensive care units and is increasingly recognized as a systemic syndrome whose consequences extend well beyond structural and functional changes confined to the kidney. Experimental studies highlight the role of inflammation and accumulation of metabolites as pivotal drivers in the cross-talk between the kidneys and distant organ systems during AKI. Whereas clinical data reveals an association between AKI and non-renal organ dysfunctions and complications. This review outlines the pathophysiological mechanisms underlying AKI-associated remote organ dysfunction, focusing on five key organ systems: the lungs, the brain, the heart, the liver and the immune system. We discuss the direct consequences of reduced kidney function alongside the repercussions of the inflammatory cascade triggered by kidney cell injury and the resulting clinical implications. Recognizing that multi-organ failure significantly influences patients’ morbidity and mortality, identifying specific pathways of organ cross-talk is essential to optimize clinical management. Finally, we evaluate novel endpoints for future AKI trials. Given that traditional long-term metrics, such as Major Adverse Kidney Events (MAKE), present significant design challenges in non-enriched populations, we analyze alternative and surrogate outcomes, including those directly related to the remote organ complications of AKI.

Read PDF

Similar papers

Review Open access Sep 2026

Poor prognosis of acute kidney injury superimposed on chronic kidney disease: potential mechanisms, risk factors and novel biomarkers

This review synthesizes previous findings and relevant research to examine the risk factors for AoCKI, as well as the potential pathophysiological mechanisms and biomarkers associated with impaired renal adaptive repair to inform the development of more effective preventive measures, diagnostic criteria, and treatment...

Lin Gao, Yu-Ming Ding, Yan-Ru Zhao et al. · 0 citations
Open access Aug 2026

Preclinical evidence for supra-clinical acute kidney injury: current biomarkers are not enough

Acute kidney injury (AKI) is a frequent complication in hospitalized patients, affecting up to 50% of those in intensive care units (ICU). It is linked to high morbidity and mortality, with severity closely tied to patient outcomes. While early biomarkers like KIM1 and NGAL can detect subclinical AKI, their practical b...

Justine Serre, David Legouis, S. Placier et al. · 1 citation
Review

: Evaluation of

Orcid Julia Jasińska · 0 citations
Review Open access Sep 2026

Kidney Failure in Cardiogenic Shock

Acute kidney injury (AKI) is a frequent and prognostically decisive complication of cardiogenic shock (CS), conferring substantially increased short- and long-term mortality. As understanding of CS has evolved beyond an isolated low-output model, AKI is increasingly recognized as a consequence of multifactorial pathoph...

T. Hanff, E. Zweck, Jackson S. Burton et al. · 0 citations
Review Open access Sep 2026

Lactate in acute kidney injury: pathobiology, risk stratification, and clinical interpretation

Abstract Lactate is frequently measured in patients with acute kidney injury (AKI), but its interpretation remains challenging because circulating lactate reflects systemic metabolic stress rather than kidney injury. Although elevated lactate levels are associated with adverse outcomes in critically ill patients with A...

Si-Ying Sun, Ze-Yang Han · 0 citations
Review Open access Sep 2026

Acute Kidney Injury-to-Chronic Kidney Disease Transition: Clinical Evidence, Pathophysiologic Mechanisms, and Emerging Role of Traditional Chinese Medicine.

The Kidney Disease: Improving Global Outcomes 2026 AKI/AKD public review draft emphasizes the AKI-AKD-CKD continuum and the need for structured follow-up, kidney function and proteinuria reassessment, and risk stratification after AKI or AKD.

Xin-Yuan Guo, Lan Wang, Wen-Jing Wu · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.